Englund J A, Mbawuike I N, Hammill H, Holleman M C, Baxter B D, Glezen W P
Dept. of Microbiology and Immunology, Baylor College of Medicine, Houston, TX 77030.
J Infect Dis. 1993 Sep;168(3):647-56. doi: 10.1093/infdis/168.3.647.
Women in the last trimester of pregnancy were given trivalent inactivated influenza virus vaccine (TIV; A/Sichuan/H3N2, A/Taiwan/H1N1, B/Victoria) or tetanus toxoid (TT). Maternal blood was drawn before immunization and at delivery (median, 5 weeks later); infant blood was obtained within 5 days of birth and 2 months later. Antibody responses to TIV and TT were determined by microneutralization assay and ELISA. T cell response was determined by lymphocyte proliferation. Maternal seroconversion to vaccine antigens was found to one or more influenza antigen in all TIV recipients and to TT in 9 of 13 TT recipients. Significantly higher IgG antibodies to maternal vaccine antigens were present in cord and infant serum. Significant blastogenic responses were seen to influenza A and B in maternal cells of TIV-immunized women but not in cord or infant lymphocytes. Maternal immunization resulted in higher infant levels of vaccine-specific IgG antibody but not in the transfer of specific T lymphocyte response(s) or production of neonatal IgM antibody.
妊娠晚期妇女接种了三价灭活流感病毒疫苗(TIV;A/四川/H3N2、A/台湾/H1N1、B/维多利亚)或破伤风类毒素(TT)。在免疫接种前和分娩时(中位数为5周后)采集母体血液;在出生后5天内和2个月后采集婴儿血液。通过微量中和试验和酶联免疫吸附测定法测定对TIV和TT的抗体反应。通过淋巴细胞增殖测定T细胞反应。发现所有接受TIV接种的妇女对一种或多种流感抗原以及13名接受TT接种的妇女中的9名对TT发生了母体血清转化。脐带血和婴儿血清中存在针对母体疫苗抗原的显著更高的IgG抗体。在接种TIV的妇女的母体细胞中观察到对甲型和乙型流感有显著的增殖反应,但在脐带血或婴儿淋巴细胞中未观察到。母体免疫导致婴儿体内疫苗特异性IgG抗体水平升高,但未导致特异性T淋巴细胞反应的转移或新生儿IgM抗体的产生。